Oral zinc reduces amyloid burden in Tg2576 mice

Christopher J. Harris, Kellen Voss, Charles Murchison, Martina Ralle, Kate Frahler, Raina Carter, Allison Rhoads, Betty Lind, Emily Robinson, Joseph Quinn

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The aggregation of amyloid-β in Alzheimer's disease can be affected by free transition metals such as copper and zinc in the brain. Addition of copper and zinc with amyloid acts to increase aggregation and copper additionally promotes the formation of reactive oxygen species. We propose that reduction of brain copper by blocking uptake of copper from the diet is a viable strategy to regulate the formation of insoluble amyloid-β in the brain of Tg2576 mice. Mice were treated with regimens of zinc acetate, which acts with metallothionein to block copper uptake in the gut, at various times along their lifespan to model prevention and treatment paradigms. We found that the mice tolerated zinc acetate well over the six month course of study. While we did not observe significant changes in cognition and behavior, there was a reduction in insoluble amyloid-β in the brain. This observation coincided with a reduction in brain copper and interestingly no change in brain zinc. Our findings show that blocking copper uptake from the diet can redistribute copper from the brain and reduce amyloid-β aggregation.

Original languageEnglish (US)
Pages (from-to)179-192
Number of pages14
JournalJournal of Alzheimer's Disease
Volume41
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Amyloid
Zinc
Copper
Brain
Zinc Acetate
Diet
Metallothionein
Cognition
Reactive Oxygen Species
Alzheimer Disease
Metals

Keywords

  • Alzheimer's disease
  • amyloid-β protein
  • copper
  • transgenic mice

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology
  • Medicine(all)

Cite this

Harris, C. J., Voss, K., Murchison, C., Ralle, M., Frahler, K., Carter, R., ... Quinn, J. (2014). Oral zinc reduces amyloid burden in Tg2576 mice. Journal of Alzheimer's Disease, 41(1), 179-192. https://doi.org/10.3233/JAD-131703

Oral zinc reduces amyloid burden in Tg2576 mice. / Harris, Christopher J.; Voss, Kellen; Murchison, Charles; Ralle, Martina; Frahler, Kate; Carter, Raina; Rhoads, Allison; Lind, Betty; Robinson, Emily; Quinn, Joseph.

In: Journal of Alzheimer's Disease, Vol. 41, No. 1, 2014, p. 179-192.

Research output: Contribution to journalArticle

Harris, CJ, Voss, K, Murchison, C, Ralle, M, Frahler, K, Carter, R, Rhoads, A, Lind, B, Robinson, E & Quinn, J 2014, 'Oral zinc reduces amyloid burden in Tg2576 mice', Journal of Alzheimer's Disease, vol. 41, no. 1, pp. 179-192. https://doi.org/10.3233/JAD-131703
Harris CJ, Voss K, Murchison C, Ralle M, Frahler K, Carter R et al. Oral zinc reduces amyloid burden in Tg2576 mice. Journal of Alzheimer's Disease. 2014;41(1):179-192. https://doi.org/10.3233/JAD-131703
Harris, Christopher J. ; Voss, Kellen ; Murchison, Charles ; Ralle, Martina ; Frahler, Kate ; Carter, Raina ; Rhoads, Allison ; Lind, Betty ; Robinson, Emily ; Quinn, Joseph. / Oral zinc reduces amyloid burden in Tg2576 mice. In: Journal of Alzheimer's Disease. 2014 ; Vol. 41, No. 1. pp. 179-192.
@article{6793b16f06d44cae955d044069bfea6c,
title = "Oral zinc reduces amyloid burden in Tg2576 mice",
abstract = "The aggregation of amyloid-β in Alzheimer's disease can be affected by free transition metals such as copper and zinc in the brain. Addition of copper and zinc with amyloid acts to increase aggregation and copper additionally promotes the formation of reactive oxygen species. We propose that reduction of brain copper by blocking uptake of copper from the diet is a viable strategy to regulate the formation of insoluble amyloid-β in the brain of Tg2576 mice. Mice were treated with regimens of zinc acetate, which acts with metallothionein to block copper uptake in the gut, at various times along their lifespan to model prevention and treatment paradigms. We found that the mice tolerated zinc acetate well over the six month course of study. While we did not observe significant changes in cognition and behavior, there was a reduction in insoluble amyloid-β in the brain. This observation coincided with a reduction in brain copper and interestingly no change in brain zinc. Our findings show that blocking copper uptake from the diet can redistribute copper from the brain and reduce amyloid-β aggregation.",
keywords = "Alzheimer's disease, amyloid-β protein, copper, transgenic mice",
author = "Harris, {Christopher J.} and Kellen Voss and Charles Murchison and Martina Ralle and Kate Frahler and Raina Carter and Allison Rhoads and Betty Lind and Emily Robinson and Joseph Quinn",
year = "2014",
doi = "10.3233/JAD-131703",
language = "English (US)",
volume = "41",
pages = "179--192",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Oral zinc reduces amyloid burden in Tg2576 mice

AU - Harris, Christopher J.

AU - Voss, Kellen

AU - Murchison, Charles

AU - Ralle, Martina

AU - Frahler, Kate

AU - Carter, Raina

AU - Rhoads, Allison

AU - Lind, Betty

AU - Robinson, Emily

AU - Quinn, Joseph

PY - 2014

Y1 - 2014

N2 - The aggregation of amyloid-β in Alzheimer's disease can be affected by free transition metals such as copper and zinc in the brain. Addition of copper and zinc with amyloid acts to increase aggregation and copper additionally promotes the formation of reactive oxygen species. We propose that reduction of brain copper by blocking uptake of copper from the diet is a viable strategy to regulate the formation of insoluble amyloid-β in the brain of Tg2576 mice. Mice were treated with regimens of zinc acetate, which acts with metallothionein to block copper uptake in the gut, at various times along their lifespan to model prevention and treatment paradigms. We found that the mice tolerated zinc acetate well over the six month course of study. While we did not observe significant changes in cognition and behavior, there was a reduction in insoluble amyloid-β in the brain. This observation coincided with a reduction in brain copper and interestingly no change in brain zinc. Our findings show that blocking copper uptake from the diet can redistribute copper from the brain and reduce amyloid-β aggregation.

AB - The aggregation of amyloid-β in Alzheimer's disease can be affected by free transition metals such as copper and zinc in the brain. Addition of copper and zinc with amyloid acts to increase aggregation and copper additionally promotes the formation of reactive oxygen species. We propose that reduction of brain copper by blocking uptake of copper from the diet is a viable strategy to regulate the formation of insoluble amyloid-β in the brain of Tg2576 mice. Mice were treated with regimens of zinc acetate, which acts with metallothionein to block copper uptake in the gut, at various times along their lifespan to model prevention and treatment paradigms. We found that the mice tolerated zinc acetate well over the six month course of study. While we did not observe significant changes in cognition and behavior, there was a reduction in insoluble amyloid-β in the brain. This observation coincided with a reduction in brain copper and interestingly no change in brain zinc. Our findings show that blocking copper uptake from the diet can redistribute copper from the brain and reduce amyloid-β aggregation.

KW - Alzheimer's disease

KW - amyloid-β protein

KW - copper

KW - transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=84902260520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902260520&partnerID=8YFLogxK

U2 - 10.3233/JAD-131703

DO - 10.3233/JAD-131703

M3 - Article

VL - 41

SP - 179

EP - 192

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 1

ER -